Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity

Creative Commons License

KARA Z., Akcin R., DEMİR A. N. , DİNÇ H. Ö. , Taskin H. E. , KOCAZEYBEK B. S. , ...More

OBESITY SURGERY, 2022 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Publication Date: 2022
  • Doi Number: 10.1007/s11695-022-06181-y
  • Title of Journal : OBESITY SURGERY
  • Keywords: Severe obesity, Vaccines, Antibody response, INFLAMMATION, COVID-19


Aim Obesity is a disease complicating the course of COVID-19 and SARS-CoV-2 vaccine effectiveness in adults with obesity may be compromised. Our aim is to investigate the spike-protein receptor-binding domain antibody titers against BNT162b2 mRNA and inactivated SARS-CoV-2 (CoronaVac) vaccines in people with severe obesity. It is anticipated that the results to be obtained may provide invaluable information about future SARS-CoV-2 vaccination strategies in this vulnerable population.